GLP1R and Alzheimer disease: Liraglutide, an acetylated analogue of GLP‐1, has been shown to reverse memory impairments and reduced synaptic plasticity (LTP) in the hippocampus of transgenic mouse models of AD (McClean & Hoelscher, 2014a; McClean et al., 2011).